280 related articles for article (PubMed ID: 35408894)
21. Notch signaling in cancer.
Miele L; Golde T; Osborne B
Curr Mol Med; 2006 Dec; 6(8):905-18. PubMed ID: 17168741
[TBL] [Abstract][Full Text] [Related]
22. Targeting cancer stem cells by nutraceuticals for cancer therapy.
Chu M; Zheng C; Chen C; Song G; Hu X; Wang ZW
Semin Cancer Biol; 2022 Oct; 85():234-245. PubMed ID: 34273521
[TBL] [Abstract][Full Text] [Related]
23. The role of cancer stem cells in the anti-carcinogenicity of curcumin.
Norris L; Karmokar A; Howells L; Steward WP; Gescher A; Brown K
Mol Nutr Food Res; 2013 Sep; 57(9):1630-7. PubMed ID: 23900994
[TBL] [Abstract][Full Text] [Related]
24. Targeting Notch in oncology: the path forward.
Majumder S; Crabtree JS; Golde TE; Minter LM; Osborne BA; Miele L
Nat Rev Drug Discov; 2021 Feb; 20(2):125-144. PubMed ID: 33293690
[TBL] [Abstract][Full Text] [Related]
25. Molecular mechanisms of curcumin action: signal transduction.
Shehzad A; Lee YS
Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
[TBL] [Abstract][Full Text] [Related]
26. Targeting cancer stem-like cells using dietary-derived agents - Where are we now?
Khan S; Karmokar A; Howells L; Thomas AL; Bayliss R; Gescher A; Brown K
Mol Nutr Food Res; 2016 Jun; 60(6):1295-309. PubMed ID: 27060283
[TBL] [Abstract][Full Text] [Related]
27. Rational targeting of Notch signaling in cancer.
Rizzo P; Osipo C; Foreman K; Golde T; Osborne B; Miele L
Oncogene; 2008 Sep; 27(38):5124-31. PubMed ID: 18758481
[TBL] [Abstract][Full Text] [Related]
28. Specific Targeting of Notch Ligand-Receptor Interactions to Modulate Immune Responses: A Review of Clinical and Preclinical Findings.
Goruganthu MUL; Shanker A; Dikov MM; Carbone DP
Front Immunol; 2020; 11():1958. PubMed ID: 32922403
[TBL] [Abstract][Full Text] [Related]
29. Alpinetin targets glioma stem cells by suppressing Notch pathway.
Wang J; Yan Z; Liu X; Che S; Wang C; Yao W
Tumour Biol; 2016 Jul; 37(7):9243-8. PubMed ID: 26768745
[TBL] [Abstract][Full Text] [Related]
30. The Notch pathway is important in maintaining the cancer stem cell population in pancreatic cancer.
Abel EV; Kim EJ; Wu J; Hynes M; Bednar F; Proctor E; Wang L; Dziubinski ML; Simeone DM
PLoS One; 2014; 9(3):e91983. PubMed ID: 24647545
[TBL] [Abstract][Full Text] [Related]
31. Notch signaling in serous ovarian cancer.
Groeneweg JW; Foster R; Growdon WB; Verheijen RH; Rueda BR
J Ovarian Res; 2014 Nov; 7():95. PubMed ID: 25366565
[TBL] [Abstract][Full Text] [Related]
32. Cellular signaling perturbation by natural products.
Sarkar FH; Li Y; Wang Z; Kong D
Cell Signal; 2009 Nov; 21(11):1541-7. PubMed ID: 19298854
[TBL] [Abstract][Full Text] [Related]
33. Notch signaling proteins: legitimate targets for cancer therapy.
Wang Z; Li Y; Sarkar FH
Curr Protein Pept Sci; 2010 Sep; 11(6):398-408. PubMed ID: 20491628
[TBL] [Abstract][Full Text] [Related]
34. Notch signaling in cancer stem cells.
Wang J; Sullenger BA; Rich JN
Adv Exp Med Biol; 2012; 727():174-85. PubMed ID: 22399347
[TBL] [Abstract][Full Text] [Related]
35. Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells.
Espinoza I; Miele L
Cancer Lett; 2013 Nov; 341(1):41-5. PubMed ID: 23973264
[TBL] [Abstract][Full Text] [Related]
36. Notch Signaling: A Potential Therapeutic Target for Hematologic Malignancies.
Gao L; Yuan K; Ding W; Lin M
Crit Rev Eukaryot Gene Expr; 2016; 26(3):239-46. PubMed ID: 27650987
[TBL] [Abstract][Full Text] [Related]
37. Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner.
Neradugomma NK; Subramaniam D; Tawfik OW; Goffin V; Kumar TR; Jensen RA; Anant S
Carcinogenesis; 2014 Apr; 35(4):795-806. PubMed ID: 24265293
[TBL] [Abstract][Full Text] [Related]
38. Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways.
Takebe N; Harris PJ; Warren RQ; Ivy SP
Nat Rev Clin Oncol; 2011 Feb; 8(2):97-106. PubMed ID: 21151206
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of Notch Signaling Pathway as an Effective Chemosensitizer for Cancer Treatment.
Majidinia M; Alizadeh E; Yousefi B; Akbarzadeh M; Zarghami N
Drug Res (Stuttg); 2016 Nov; 66(11):571-579. PubMed ID: 27701712
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin selects for stem-like cells in osteosarcoma by activating Notch signaling.
Yu L; Fan Z; Fang S; Yang J; Gao T; Simões BM; Eyre R; Guo W; Clarke RB
Oncotarget; 2016 May; 7(22):33055-68. PubMed ID: 27102300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
